CONTEXT: High-density lipoprotein (HDL) particles perform numerous vascular-protective functions. Animal studies demonstrate that exposure to fine or ultrafine particulate matter (PM) can promote HDL dysfunction. However, the impact of PM on humans remains unknown. OBJECTIVE: We aimed to determine the effect of exposure to coarse concentrated ambient particles (CAP) on several metrics of HDL function in healthy humans. METHODS:Thirty-two adults (25.9 ± 6.6 years) were exposed to coarse CAP [76.2 ± 51.5 µg·m(-3)] in a rural location and filtered air (FA) for 2 h in a randomized double-blind crossover study. Venous blood collected 2- and 20-h post-exposures was measured for HDL-mediated efflux of [(3)H]-cholesterol from cells and 20-h exposures for HDL anti-oxidant capacity by a fluorescent assay and paraoxonase activity. The changes [median (first, third quartiles)] between exposures among 29 subjects with available results were compared by matched Wilcoxon tests. RESULTS:HDL-mediated cholesterol efflux capacity did not differ between exposures at either time point [16.60% (15.17, 19.19) 2-h post-CAP versus 17.56% (13.43, 20.98) post-FA, p = 0.768 and 14.90% (12.47, 19.15) 20-h post-CAP versus 17.75% (13.22, 23.95) post-FA, p = 0.216]. HOI [0.26 (0.24, 0.35) versus 0.28 (0.25, 0.40), p = 0.198] and paraoxonase activity [0.54 (0.39, 0.82) versus 0.60 μmol·min(-1 )ml plasma(-1) (0.40, 0.85), p = 0.137] did not differ 20-h post-CAP versus FA, respectively. CONCLUSIONS: Brief inhalation of coarse PM from a rural location did not acutely impair several facets of HDL functionality. Whether coarse PM derived from urban sites, fine particles or longer term PM exposures can promote HDL dysfunction warrant future investigations.
RCT Entities:
CONTEXT: High-density lipoprotein (HDL) particles perform numerous vascular-protective functions. Animal studies demonstrate that exposure to fine or ultrafine particulate matter (PM) can promote HDL dysfunction. However, the impact of PM on humans remains unknown. OBJECTIVE: We aimed to determine the effect of exposure to coarse concentrated ambient particles (CAP) on several metrics of HDL function in healthy humans. METHODS: Thirty-two adults (25.9 ± 6.6 years) were exposed to coarse CAP [76.2 ± 51.5 µg·m(-3)] in a rural location and filtered air (FA) for 2 h in a randomized double-blind crossover study. Venous blood collected 2- and 20-h post-exposures was measured for HDL-mediated efflux of [(3)H]-cholesterol from cells and 20-h exposures for HDL anti-oxidant capacity by a fluorescent assay and paraoxonase activity. The changes [median (first, third quartiles)] between exposures among 29 subjects with available results were compared by matched Wilcoxon tests. RESULTS: HDL-mediated cholesterol efflux capacity did not differ between exposures at either time point [16.60% (15.17, 19.19) 2-h post-CAP versus 17.56% (13.43, 20.98) post-FA, p = 0.768 and 14.90% (12.47, 19.15) 20-h post-CAP versus 17.75% (13.22, 23.95) post-FA, p = 0.216]. HOI [0.26 (0.24, 0.35) versus 0.28 (0.25, 0.40), p = 0.198] and paraoxonase activity [0.54 (0.39, 0.82) versus 0.60 μmol·min(-1 )ml plasma(-1) (0.40, 0.85), p = 0.137] did not differ 20-h post-CAP versus FA, respectively. CONCLUSIONS: Brief inhalation of coarse PM from a rural location did not acutely impair several facets of HDL functionality. Whether coarse PM derived from urban sites, fine particles or longer term PM exposures can promote HDL dysfunction warrant future investigations.
Authors: Parin J Patel; Amit V Khera; Kashif Jafri; Robert L Wilensky; Daniel J Rader Journal: J Am Coll Cardiol Date: 2011-11-08 Impact factor: 24.094
Authors: Jesus A Araujo; Berenice Barajas; Michael Kleinman; Xuping Wang; Brian J Bennett; Ke Wei Gong; Mohamad Navab; Jack Harkema; Constantinos Sioutas; Aldons J Lusis; Andre E Nel Journal: Circ Res Date: 2008-01-17 Impact factor: 17.367
Authors: Robert D Brook; Bruce Urch; J Timothy Dvonch; Robert L Bard; Mary Speck; Gerald Keeler; Masako Morishita; Frank J Marsik; Ali S Kamal; Niko Kaciroti; Jack Harkema; Paul Corey; Frances Silverman; Diane R Gold; Greg Wellenius; Murray A Mittleman; Sanjay Rajagopalan; Jeffrey R Brook Journal: Hypertension Date: 2009-07-20 Impact factor: 10.190
Authors: Roger D Peng; Howard H Chang; Michelle L Bell; Aidan McDermott; Scott L Zeger; Jonathan M Samet; Francesca Dominici Journal: JAMA Date: 2008-05-14 Impact factor: 56.272
Authors: Sara D Adar; Lianne Sheppard; Sverre Vedal; Joseph F Polak; Paul D Sampson; Ana V Diez Roux; Matthew Budoff; David R Jacobs; R Graham Barr; Karol Watson; Joel D Kaufman Journal: PLoS Med Date: 2013-04-23 Impact factor: 11.069
Authors: Griffith Bell; Samia Mora; Philip Greenland; Michael Tsai; Ed Gill; Joel D Kaufman Journal: Arterioscler Thromb Vasc Biol Date: 2017-04-13 Impact factor: 8.311
Authors: Zhili Yao; Jessica M Mates; Alana M Cheplowitz; Lindsay P Hammer; Andrei Maiseyeu; Gary S Phillips; Mark D Wewers; Murugesan V S Rajaram; John M Robinson; Clark L Anderson; Latha P Ganesan Journal: J Immunol Date: 2016-08-17 Impact factor: 5.422
Authors: Anna Vachaparampil Mathew; Joyce Yu; Yanhong Guo; Jaeman Byun; Y Eugene Chen; Lu Wang; Mochuan Liu; Robert L Bard; Masako Morishita; Wei Huang; Jianping Li; Jack R Harkema; Sanjay Rajagopalan; Subramaniam Pennathur; Robert D Brook Journal: Am J Cardiol Date: 2018-07-11 Impact factor: 2.778
Authors: Fatima Cabral; Mustafa Al-Rahem; John Skaggs; Thushara A Thomas; Naresh Kumar; Qian Wu; Paolo Fadda; Lianbo Yu; John M Robinson; Jonghan Kim; Ekta Pandey; Xinghui Sun; Wael N Jarjour; Murugesan V S Rajaram; Edward N Harris; Latha P Ganesan Journal: iScience Date: 2021-10-25
Authors: Gajalakshmi Ramanathan; Fen Yin; Mary Speck; Chi-Hong Tseng; Jeffrey R Brook; Frances Silverman; Bruce Urch; Robert D Brook; Jesus A Araujo Journal: Part Fibre Toxicol Date: 2016-05-24 Impact factor: 9.400